methylene blue has been researched along with carboplatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborti, PR; Garner, CM; Hubbold, LM | 1 |
| Al-Dybiat, I; Arefi-Khonsari, F; Baitukha, A; Mirshahi, M; Pocard, M; Pulpytel, J; Valinataj-Omran, A | 1 |
2 other study(ies) available for methylene blue and carboplatin
| Article | Year |
|---|---|
In vitro testing of platinum-based drugs on a panel of human ovarian tumour cell lines.
Topics: Antineoplastic Agents; Carboplatin; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Methylene Blue; Ovarian Neoplasms; Tumor Cells, Cultured | 2002 |
Optimization of a low pressure plasma process for fabrication of a Drug Delivery System (DDS) for cancer treatment.
Topics: Animals; Antineoplastic Agents; Carboplatin; Drug Delivery Systems; Humans; Membranes, Artificial; Methylene Blue; Neoplasms; Plasma Gases | 2019 |